Combination therapy using oral S-1 and targeted agents against human tumor xenografts in nude mice

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-01 ,pp. : 755-762

Spandidos Publications

Access to resources Recommend Favorite

BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts

By Boven E.   Verschraagen M.   Hulscher T.M.   Erkelens C.A.M.   Hausheer F.H.   Pinedo H.M.   van der Vijgh W.J.F.  

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1148-1156

Elsevier

Access to resources Recommend Favorite

Molecular Mechanism Behind the Synergistic Activity of Diphenylmethyl Selenocyanate and Cisplatin Against Murine Tumor Model

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 4, 2015-01 ,pp. : 501-510

Bentham Science Publishers

Access to resources Recommend Favorite

Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice

By Allegrini Giacomo   Goulette Frederick   Darnowski James   Calabresi Paul  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 261-266

Springer Publishing Company

Access to resources Recommend Favorite

Avastin® in combination with gemcitabine and cisplatin significantly inhibits tumor angiogenesis and increases the survival rate of human A549 tumor-bearing mice

By        

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2180-2184

Spandidos Publications

Access to resources Recommend Favorite